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Abstract
Background
Onchocerca volvulus infection can result in blindness, itching and skin lesions. Previous
research concentrated on blindness.
Methods
A clinical classification system of the cutaneous changes in onchocerciasis was used for the
first time in this study within the context of an early ivermectin drug trial in the savanna region
of Kaduna State, northern Nigeria. Skin examinations were performed in 6,790 individuals
aged 5+ years in endemic communities and 1,343 individuals in nonendemic communities.
Results / Discussion
There was increased risk for all forms of onchocercal skin disease in endemic communities
with the most common finding being the presence of nodules (1,438 individuals, 21.2%), fol-
lowed by atrophy (367, 6.1% of those < 50 years), acute papular onchodermatitis, APOD
(233, 3.4%), depigmentation (216, 3.2%) and chronic papular onchodermatitis, CPOD (155,
2.3%). A further 645 individuals (9.5%) complained of pruritus but had completely normal
skin. APOD was more common in males whereas atrophy, hanging groin and nodules were
more common in females. After controlling for age and sex, microfilarial positivity was a risk
factor for CPOD, depigmentation, hanging groin and nodules (OR 1.54, p = 0.046; OR 2.29,
p = 0.002; OR 2.18, p = 0.002 and OR 3.80, p <0.001 respectively). Comparable results
were found using presence of nodules as the marker for infection. Microfilarial load showed
similar, though weaker, results. A total of 2621(38.6%) endemic residents had itching with
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normal skin, or had one or more types of onchocercal skin disease including nodules, which
may be considered as a composite index of the overall prevalence of onchocercal skin
disease.
Conclusion
Significant levels of onchocercal skin disease were documented in this savanna area, which
subsequently resulted in a reassessment of the true burden of skin disease in onchocercia-
sis. This paper represents the first detailed report of the association of onchocercal skin dis-
ease with markers for onchocercal infection.
Author summary
Onchocerciasis is a tropical parasitic infection caused by the nematode worm Onchocerca vol-
vulus. The disease mainly occurs across tropical Africa and infection can result in blindness,
debilitating itching and a variety of skin changes. Initial research concentrated mainly on the
problem of blindness. A number of studies on onchocercal skin disease were performed but
were difficult to interpret and compare because of the use of inconsistent terminology. Within
the setting of one of the early trials of ivermectin in a savanna area of northern Nigeria, where
there were known high rates of onchocercal blindness, we used a novel clinical classification
of the skin changes in onchocerciasis. We identified significant levels of itching and various
forms of onchocercal skin disease within these endemic communities. A positive skin-snip
result proved to be a significant risk factor for the presence of chronic papular onchodermati-
tis (CPOD), depigmentation, hanging groin and onchocercal nodules. Comparable results
were found when the presence of nodules was used as the marker for infection and similar,
though weaker odds ratios were found with microfilarial load per se. The findings triggered a
reassessment of the true burden of skin disease in onchocerciasis. It is the first detailed report
of the association between onchocercal skin disease and markers of infection.
Introduction
Onchocerciasis affects approximately 17 million people worldwide [1] with the main burden
of disease occurring throughout tropical Africa. The consequences of infection with the nema-
tode Onchocerca volvulus include blindness, debilitating pruritus and skin lesions. Initial
research concentrated on blindness because of its devastating socio-economic impact. Prior to
any control activities in West Africa, it was common to see entire villages near rivers, which
were the breeding sites for the Simulium vector, completely abandoned for less fertile land else-
where [2].
It is established that the two epidemiological patterns of ocular onchocerciasis result from
two strains of the O. volvulus parasite. These can be differentiated by DNA sequencing [3;4]. A
severe form of ocular disease occurs primarily in savanna areas, where communities often suf-
fer from a high prevalence of onchocercal blindness. Conversely, in rainforest areas onchocer-
cal blindness is less common. The Onchocerciasis Control Programme, OCP (1974–2002) was
a large-scale, multi-country programme which aimed to control the vector in countries with
high rates of blinding onchocerciasis by regular aerial larviciding of rivers. At its peak, the
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programme included eleven countries in West Africa and, although expensive, was very suc-
cessful in interrupting transmission [5].
In 1987, Merck & Co., Inc. announced the donation of Mectizan (ivermectin) for the treat-
ment of onchocerciasis worldwide for as long as necessary. The early large-scale ivermectin tri-
als, including the study described here, were conducted in non-OCP endemic areas, known to
have high rates of onchocercal blindness. As ivermectin is mainly microfilaricidal it is neces-
sary to continue annual treatment of the human host population throughout the adult female
worms’ life-span of up to 14–16 years.
Up until this time, there had been a number of studies on onchocercal skin disease [6–14]
but they were difficult to compare because of the lack of a scheme to describe the cutaneous
changes. The true burden of skin disease caused by onchocerciasis in any endemic area and
globally was therefore unclear. Based on previous field work in Sudan (R.J. Hay, C.D. Macken-
zie and J.W. Williams unpublished observations) and in Ecuador [15], a new skin classification
scheme [16] was used for the first time in the study described here.
The categories in the clinical classification used for the first time in this study were "consis-
tent with" rather than specific for onchocerciasis. Each subtype has its own clinical differential
diagnosis. The objectives of this study were to field test the skin classification scheme on a
large scale and to determine the prevalence of onchocerciasis-related skin changes in this
savanna setting, a region which was already known to have high rates of onchocercal blind-
ness. In addition, we aimed to explore the association of factors such as age, gender and mark-
ers of infection with various forms of onchocercal skin disease.
The data were collected during 1988–1989 prior to commencement of ivermectin therapy.
The urgent focus of the work at the time concerned the ocular findings and impact of ivermec-
tin therapy. At the time the skin classification system was published and was adopted for a
WHO multi-country study that established the true public health importance of onchocercal
skin disease. Following the multi-country study, the African Programme for Onchocerciasis
Control, APOC, using community-directed treatment with ivermectin, was established in many
countries. Issues such as ivermectin treatment needing to be repeated annually for many years,
possible ivermectin resistance and side-effects in areas co-endemic with Loa-loa have encour-
aged the continued search for novel therapies for onchocerciasis. The subsequent widespread
use of ivermectin has now rendered our baseline dataset unique in having skinsnip results com-
bined with detailed and validated records of skin pathology in an untreated population. The
association of onchocercal skin changes with levels of infection is critical in improving under-
standing of pathogenesis and aiding the search for new treatments for onchocerciasis. We have
therefore further examined the data and report the findings here and wish to ensure the dataset
is available to the wider research community.
Methods
Ethics statement
The study was approved by the Medical Ethical Committee of Ahmadu Bello University, Zaria,
Nigeria, Project Number ESC/89/00024. Approval for the parent project was also approved by
the Ministry of Public Health, Nigeria.
Selection of communities and registration phase
As previously described [17], the study was conducted in the guinea savanna of Kaduna State,
northern Nigeria in a subsistence farming mesoendemic area. The initial selection of commu-
nities was based on entomological data on Simulium blackfly breeding sites, the vectors being
S. damnosum ss [dominant] and S. sirbanum. In 1988, 36 villages were mapped and residential
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compounds numbered. All individuals aged 5 years and above were registered and photo-
graphed and skin snips taken. The criterion for inclusion of communities in the trial was a
microfilarial prevalence of at least 30% among those aged 20 years or above. Thirty four of the
communities met the criteria for inclusion in the study. The overall prevalence of positive skin
snips among villagers aged 5 years and above was 49% and 72% among those aged 20 years
and above.
A further two nonendemic communities with similar ethnic and socio-economic character-
istics as the endemic communities were selected in Fatika, Zaria Local Government Area of
Kaduna State. These communities served as control communities on the basis of a very low
prevalence of onchocercal infection (0.3% positive skin snips in those aged 5 years and above).
Skin snipping
Two skin snips were taken from both iliac crests in each individual, using a 2mm Holth cor-
neoscleral punch. Snips were incubated for 24–30 hours in normal saline, then weighed and
fixed in formal saline. Emergent microfilariae were later counted in Kaduna by independent
counters (3 for endemic and 2 for nonendemic communities). In case of disagreement
between counters the well was re-examined by an independent observer. The microfilarial
load per mg of skin (mf/mg) was calculated for each individual and the community microfilar-
ial load (CMFL) was calculated for each village.
Skin examinations
Within one year of registration, the study team performed ophthalmic [17] and dermatological
examinations on individuals aged 5 years and above. The skin examinations were conducted
from 1988–1989. Individuals were asked in the local language (Hausa) about the presence of
itching. Skin examinations were conducted privately in natural daylight. The presence or
absence of palpable onchocercal nodules and the various types of onchocercal skin disease
(OSD) were noted on a form using a standard clinical classification system [16]. Acute papular
onchodermatitis (APOD), chronic papular onchodermatitis (CPOD), lichenified papular
onchodermatitis (LOD), atrophy, depigmentation (DPM), hanging groin and onchocercal
nodules were documented. APOD, CPOD and LOD were collectively termed reactive skin
lesions. In order to avoid confusion with senile or age-related atrophy of the skin, onchocercal
skin atrophy was only recorded as an abnormal finding in individuals aged less than 50 years.
The categories in the clinical classification are "consistent with" rather than specific for oncho-
cerciasis and each subtype has its own clinical differential diagnosis [16]. The presence of non-
onchocercal skin disease was also recorded. All skin examinations were conducted masked to
skin snip and eye examination results.
Consent
Following preliminary discussions with the village heads, informed consent for skin snipping
and subsequent eye and skin examinations was obtained in the local Hausa language and con-
firmed with a signature or finger-print.
Data analysis
Data were double-entered onto computers with the software package DBase III+ and were
cleaned with DBase III+ and SAS/PC. Analyses were done using STATA/IC 12.0 (http://www.
stata.com). Logistic regression, both univariable and multivariable, was undertaken to investi-
gate the association between various forms of onchocercal skin disease and onchocercal
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infection (using microfilarial (mf) positivity, microfilarial load and nodules as separate mark-
ers), age and gender. Account was taken for clustering by village in all analyses by using linear-
ization-based variance estimators.
Results
Inter-observer variation study
A substantial effort was made to minimise inter-observer variation before the start of data col-
lection. An inter-observer variation study for recording itching and each of the categories of
onchocercal skin disease was conducted under similar lighting conditions by two general phy-
sicians (HNY and NN) on 291 individuals. Good Kappa values were obtained as follows: pruri-
tus with clinically normal skin = 0.68 (95% confidence intervals (CI) 0.59–0.76); APOD = 0.72
(CI 0.60–0.85); CPOD = 0.79 (CI 0.56–1.03); LOD = 1.0 (CI 0.98–1.02); atrophy = 0.84 (0.68–
1.0) and nodules = 0.83 (0.75–0.90). There were insufficient numbers of individuals with DPM
(n = 3) or hanging groin (n = 3) to allow comparision. However, these are two of the most eas-
ily identified forms of onchocerciasis-related pathology.
Endemic onchocercal communitites
A total of 8,140 individuals aged 5 years and above were registered at the time of the census
and 7,072 were present at the time of examinations one year later. Of these 6,790 consented to
a skin examination. Skin snip data was available for 6,643 (97.8% of those examined, Table 1).
Overall 3,276 (49.3% of those snipped) had positive skin snips. Of those who were skin snip
positive, the majority (1872/3276, 57.1%) had low microfilarial loads (10.00 mf/mg skin).
Non-endemic communities
A total of 1,886 individuals aged 5 years and above were registered at the time of census. Skin
examinations were conducted on 1,343 individuals. Skin snip data was available for 1,342
(99.9% of those examined, Table 1). Only 4 persons (0.3%) in the non-endemic villages had
positive skin snips, all with microfilarial loads10.00 mf/mg skin.
Onchocerciasis-related skin changes
The prevalences of skin changes consistent with onchocerciasis in endemic and nonendemic
communities are summarised in Table 2. In endemic communities the most common clinical
Table 1. Characteristics of residents who underwent skin examinations in endemic and nonendemic villages showing age, sex and microfilarial
load (mf/mg)*.
Endemic villages N = 6790 Nonendemic villages N = 1343
Male Female Male Female
Age (years) N mf/mg N mf/mg N mf/mg N mf/mg
5–14 1334 1.5 1189 0.5 266 0 233 0
15–24 560 12.7 679 6.7 135 0 164 0
25–34 478 14.0 622 10.8 95 0 118 0
35–44 409 13.4 439 13.5 78 0.004 71 0
45–54 293 12.9 290 12.5 50 0 44 0
55–64 150 16.3 155 10.4 27 0 24 0
65+ 126 13.9 66 13.3 24 0 14 0
* Number (%) skin-snipped: Endemic villages = 6,643 (97.8%); Nonenendemic villages = 1,342 (99.9%)
https://doi.org/10.1371/journal.pntd.0005489.t001
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sign was the presence of palpable onchocercal nodules in 1438 (21.2%) of the examined popu-
lation. The next most frequent finding was atrophy (367; 6.1% of those aged<50 years) fol-
lowed by APOD (233, 3.4%), depigmentation (216, 3.2%) and CPOD (155, 2.3%). Overall,
including nodules, 1976 (29.1%) persons had one or more forms of OSD. A further 645 indi-
viduals (9.5%) complained of pruritus but had completely normal skin. A total of 2621(38.6%)
of the examined endemic population were found to complain of itching with normal skin or
had one or more types of OSD including nodules, which may be considered as a composite
index of the overall prevalence of onchocercal skin disease.
In the nonendemic communities all forms of onchocercal skin disease and the presence of
itching with normal skin were rare. No cases of LOD were identified. The most common find-
ing potentially associated with onchocercal infection was atrophy in 47 persons (3.9% of those
aged< 50 years).
There was an increased risk for all forms of OSD in endemic compared with nonendemic
communities. The highest risk was seen for the presence of nodules (OR 89.94), followed by
hanging groin (OR 19.04), depigmentation (OR 11.0), APOD (OR 9.51), Reactive Skin Lesions
(OR 4.83), CPOD (OR 2.83, all p<0.001) and atrophy (OR 1.6, p = 0.001). Endemic communi-
ties also had a higher risk of itching alone with clinically normal skin (OR 5.53) and itching
alone or one or more OSD- associated findings including nodules (OR 8.45, both p<0.001).
Age and gender-specific prevalence of OSD-associated findings in
endemic communities
Figs 1–5 show age and gender-specific prevalence of onchocercal skin disease and markers of
onchocercal infection in endemic communities. Fig 1 shows the age and gender-specific preva-
lence for itching with clinically normal skin. The highest prevalence was seen in the youngest
age group of 5–14 years, with an overall trend to reduce with age.
The age and gender-specific prevalence of APOD, CPOD and reactive onchocercal skin
lesions in endemic communities are shown in Fig 2. There were only five cases of LOD, four of
Table 2. Pre-control prevalence of onchocercal skin disease in endemic and nonendemic villages.
Skin condition Endemic villages N = 6790 Nonendemic villages
N = 1343
Univariable ORd (95% CI) P value
n % (95% CI) n % (95% CI)
APOD* 233 3.4 (2.2–4.7) 5 0.4 (0.0–1.0) 9.509 (6.187–14.615) <0.001
CPOD* 155 2.3 (1.7–2.9) 11 0.8 (0.0–3.5) 2.829 (1.762–4.542) <0.001
LOD* 5 0.1 (0.0–0.16) 0 0 - -
Reactive skin lesions (i.e. APOD+/-CPOD+/-LOD*) 351 5.2 (3.7–6.6) 15 1.1 (0.7–2.9) 4.826 (3.399–6.853) <0.001
Atrophy (Individuals aged <50 yrs)a 367 6.1 (4.8–7.4) 47 3.9 (0.0–8.3) 1.611 (1.233–2.106) = 0.001
Depigmentationb 216 3.2 (2.6–3.8) 4 0.3 (0.00–1.2) 10.999 (7.362–16.433) <0.001
Hanging Groin 95 1.4 (1.0–1.8) 1 0.1 (0.0–0.3) 19.043 (11.680–31.047) <0.001
Nodules 1438 21.2 (18.0–24.4) 4 0.3 (0.0–1.3) 89.942 (58.731–137.738) <0.001
Any of the above 1976 29.1 (25.8–32.4) 68 5.1 (0.0–10.5) 7.696 (6.271–9.445) <0.001
Itching with clinically normal skinc 645 9.5 (5.5–13.5) 25 1.9 (0.0–8.0) 5.534 (3.029–10.109) <0.001
Any of the above 2,621 38.6 (32.7–44.5) 93 6.9 (0.0–18.5) 8.450 (6.117–11.672) <0.001
* APOD = Acute Papular Onchodermatitis; CPOD = Chronic Papular Onchodermatitis; LOD = Lichenified Onchodermatitis
a Denominator for individuals aged <50 yrs in endemic villages = 6,022; nonendemic villages = 1,214
bDepigmentation includes pale brown leopard skin plus complete depigmentation or typical leopard skin
cNo evidence of onchocercal skin disease, nor any other itchy skin disease
dAccount was taken for clustering by village in all analyses. Multivariable OR, corrected for age group and sex revealed similar results (S1 Table).
https://doi.org/10.1371/journal.pntd.0005489.t002
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whom were female. Three were aged 15–24 and the remaining two were older. The highest
prevalence of APOD was seen in those aged 5–14. Whilst the prevalence was fairly constant in
older females, it possibly rose again in males aged 45 years or more. CPOD was more common
in those aged 45 years or more. The overall prevalence of reactive skin disease reflects these
findings. Among females there was a small rise in prevalence with age. Among males preva-
lence was lowest between 15 and 44 years of age.
Fig 3 shows the age and gender distribution of markers of chronic disease. All markers of
chronic disease increased strongly with age: atrophy and depigmentation from 25 years
onwards and hanging groin from 35 years onwards. Atrophy and hanging groin had a consis-
tently higher prevalence in females.There was little gender difference with depigmentation.
A composite index of the overall prevalence of onchocercal skin disease was created of itch-
ing alone or any onchocercal skin lesion including nodules. Fig 4 shows the age and gender-
specific prevalence of this index. There was a marked increase in prevalence with age for both
sexes, with a trend for prevalence in females aged 25 years and above. In both sexes the preva-
lence plateaued from age 35 years onwards, reaching around 70% in females and 60% in
males.
Fig 5 shows age- and gender-specific prevalence of infection as determined by mf positivity
and presence of nodules. The prevalence of mf positivity rose steeply with age, reaching a pla-
teau of approximately 70% from the age of 15 years onwards in males and 25 years onwards in
females. In contrast there was a steady rise in nodule prevalence until the age of 45 years. In
the older age groups nodules were consistently more prevalent in females. Nodule prevalence
plateaued at approximately 40% in males and 50% in females.
The prevalence of the various types of onchocercal skin disease were examined by two
markers of onchocercal infection, skin snip positivity and presence of palpable onchocercal
nodule (S2 Table). CPOD, atrophy, depigmentation and hanging groin were more prevalent
among those with positive skin snips and among those with nodules. Neither APOD nor itch-
ing without skin lesions were more common among those with these markers of onchocercal
infection.
Fig 1. Age and gender-specific prevalence of itching with clinically normal skin in endemic savanna
communities, Kaduna State, Northern Nigeria. Error bars represent mean and 95% CI.
https://doi.org/10.1371/journal.pntd.0005489.g001
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Fig 2. Age and gender-specific prevalence of a) acute papular onchodermatitis, b) chronic papular
onchodermatiits and c) reactive skin lesions (i.e. acute papular onchodermatitis +/- chronic papular
Pre-control onchocercal skin disease in Northern Nigeria
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Logistic regression analyses
Multivariable logistic regression analyses were performed to investigate the association of each
form of onchocercal skin disease with infection after controlling for age and gender (Table 3).
Three models were created using mf positivity, mf load or nodules as the marker of infection.
Mf positivity was associated with increased risk of CPOD (OR = 1.54, p = 0.046), depigmenta-
tion (OR = 2.29, p = 0.002), hanging groin (OR = 2.18, p value = 0.002) and nodules (OR = 3.80,
p<0.001).
Comparable increased risks were noted when the presence of nodules was used as the
marker of infection (CPOD OR = 1.59, p = 0.016; depigmentation OR = 1.70, p = 0.001; hang-
ing groin OR = 2.76, p<0.001). Nodules were also a risk factor for atrophy (OR 1.53,
p = 0.001).
Similar, though weaker, increased risks were found when mf load per se was used as the
marker of infection (atrophy OR = 1.24, p = 0.014; depigmentation OR = 1.43, p<0.001; hang-
ing groin OR = 1.30, p<0.001; and nodules OR = 1.86, p<0.001).
After controlling for age and sex in the multivariable analysis, mf load was protective for
the presence of itching alone with clinically normal skin (OR 0.80, p = 0.026). After controlling
for age and sex there were no significant associations for APOD with microfilarial positivity,
mf load or presence of nodules.
In the multivariate analysis the composite index of onchocercal skin disease (itching alone
with clinically normal skin or any onchocercal skin disease including nodules) was signifi-
cantly associated with mf positivity (OR = 2.21, p<0.001). The association was weaker if mf
load was used as the marker of infection (OR = 1.56, p<0.001).
Prevalence of non-onchocercal skin disease
The prevalence of non-onchocercal skin disease by meso- and nonendemic communities is
shown in Table 4. Overall the prevalence of non-onchocercal skin disease was lower in the
endemic communities (53.7% vs 69.1%, OR 0.52, p = 0.024).
The most common non-onchocercal skin disease was acne which was only half as prevalent
in endemic communities. In contrast pyoderma, scabies and miliaria were more prevalent in
the endemic communities.
Findings of pityriasis versicolor, dermatophyte infection and insect bites were all less com-
mon in the endemic communities. A large number of other skin conditions were also
recorded, which were generally less prevalent in the endemic communities. These included
keloids, eczema, burn scars, warts and erythema ab igne.
Discussion
This study reports the first use of the classification of the cutaneous changes associated with
onchocerciasis on a large scale. It is worth emphasizing that this scheme, which is based purely
on clinical signs, was applied without the physician being aware of the individual’s skin snip
status or results of their eye examination. The clinical signs of each type of onchocercal skin
disease are relatively non-specific and hence each category has its own list of clinical differen-
tial diagnoses [16]. The most commonly observed onchocercal skin finding in the endemic
communities was onchocercal nodules (21.2%) followed by cutaneous atrophy (6.1% of indi-
viduals aged<50 years), APOD (3.4%) and depigmentation (3.2%). LOD was rare in this
onchodermatitis +/- lichenified onchodermatitis) in endemic savanna communities, Kaduna State, Northern
Nigeria. Error bars represent mean and 95% CI.
https://doi.org/10.1371/journal.pntd.0005489.g002
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Fig 3. Age and gender-specific prevalence of a) atrophy in individuals aged < 50 years, b) depigmentation
and c) hanging groin in endemic savanna communities, Kaduna State, Northern Nigeria. Error bars represent
mean and 95% CI.
https://doi.org/10.1371/journal.pntd.0005489.g003
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savanna area with only five cases identified. Careful clinical examination highlighted a further
group of individuals (9.5% of endemic residents) who complained of itching but had clinically
normal skin. Thus, within this endemic region, a total of 38.6% of the population aged 5 years
and above had itching with normal skin or one or more forms of OSD including nodules. This
demonstrates a remarkably high overall prevalence of onchocercal skin disease in these com-
munities. Although savanna areas of sub-Saharan Africa were known to have high burdens of
blinding onchocercal eye disease, this was the first time high levels of onchocercal skin disease
had been documented in a savanna region.
The prevalence of onchocercal skin disease in these communities is an underestimate since
a diagnosis of atrophy was limited to those aged less than 50 years in order to avoid confusion
with senile atrophy of the skin. APOD, CPOD and LOD are by definition, itchy conditions
and the degree of the burden of itching suffered by these residents has not been captured. The
true prevalence of onchocercal-induced atrophy and itching in the community will therefore
be higher.
As mentioned previously, the various skin changes consistent with onchocerciasis may be
clinically non-specific. The strong positive associations of CPOD, depigmentation and hang-
ing groin with microfilarial positivity, independent of age and sex, show these classification
sub-groupings are relevant to onchocercal infection. It is possible that the relationship of these
clinical findings with onchocercal infection may be even stronger since it is known that skin
snip sensitivity is increased with higher numbers of skin snips. Sensitivity for infection may be
even further increased by the use of PCR or LAMP of skin snips [18,19]. CPOD, atrophy,
depigmentation and hanging groin were also associated with the presence of nodules, and
atrophy, depigmentation, hanging groin and nodules were all associated with microfilarial
load.
It is possible that individuals with pruritus but clinically normal skin had early, light infec-
tions which were not always detectable by the routine number of two skin snips performed in
this study and this may explain why no association with mf positivity could be documented in
the multivariable regression analyses. Paradoxically mf load was found to be inversely associ-
ated with itching alone. The reason for this is unclear.
Fig 4. Age and gender-specific prevalence of itching alone or any onchocercal skin disease including
nodules in endemic savanna communities, Kaduna State, Northern Nigeria. Error bars represent mean
and 95% CI.
https://doi.org/10.1371/journal.pntd.0005489.g004
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Similarly APOD, which was more common in 5–14 year olds who presumably also had
early, light, onchocercal infections, did not show associations with infection in this study.
Microfilarial remnants have previously been demonstrated in epidermal microabscesses in
skin biopsies of APOD (Murdoch et al. Brit J Dermatol 1990: 123 (Suppl 37):28).
There were only five cases of LOD, three of whom were microfilaria positive. LOD is associ-
ated with hyperimmune host immune responses, skin snips are often negative and microfilar-
iae are difficult to find on skin biopsy [11]. Atrophy, hanging groin and nodules were all more
common in females.
There were only 4 persons skin snip positive in the nonendemic villages. The prevalence of
all forms of skin disease consistent with onchocercal infection was very low in nonendemic vil-
lages, supporting the clinical classification scheme as consistent with onchocercal infection. A
caveat is that the clinical observers were aware that they were in a nonendemic area. It is
Fig 5. Age and gender-specific prevalence of a) microfilarial positivity and b) nodules in endemic savanna
communities, Kaduna State, Northern Nigeria. Error bars represent mean and 95% CI.
https://doi.org/10.1371/journal.pntd.0005489.g005
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Table 3. Univariable and multivariable logistic regression analyses for itching alone and onchocercal skin disease outcomes in endemic villages.
Account was taken for clustering by village in all analyses. Each of the multivariate models included risk factors of agea, sexb, plus either i) mf positivity, ii) mf
load or iii) presence of nodules as the marker for infection.
Outcome Risk Factor Univariable OR (95% C I) p Multivariable OR (95% C I) using mf positivity p
Itching alone Mf positivity 0.638 (0.414–0.985) = 0.043 0.843 (0.591–1.202) = 0.335
Mf loadc 0.705 (0.551–0.901) = 0.007 0.802 (0.661–0.973) = 0.026
APOD Mf positivity 0.705 (0.494–1.005) = 0.053 1.121 (0.725–1.734) = 0.597
Mf load 0.798 (0.655–0.973) = 0.027 1.014 (0.807–1.272) = 0.905
Nodulesd 0.718 (0.477–1.081) = 0.109 1.097 (0.679–1.773) = 0.697
CPOD Mf positivity 2.267 (1.475–3.484) <0.001 1.536 (1.008–2.341) = 0.046
Mf load 1.402 (1.182–1.662) <0.001 1.160 (0.947–1.422) = 0.146
Nodules 2.342 (1.781–3.081) <0.001 1.589 (1.097–2.300) = 0.016
Reactive Skin Lesions Mf positivity 1.048 (0.757–1.452) = 0.769 1.209 (0.848–1.724) = 0.283
Mf load 1.008 (0.850–1.195) = 0.923 1.066 (0.880–1.291) = 0.504
Nodules 1.221 (0.912–1.634) = 0.173 1.351 (0.951–1.919) = 0.091
Atrophy (<50 yrs) Mf positivity 4.993 (3.690–6.755) <0.001 1.390 (0.941–2.052) = 0.095
Mf load 1.940 (1.741–2.162) <0.001 1.241 (1.047–1.470) = 0.014
Nodules 4.597 (3.777–5.595) <0.001 1.534 (1.206–1.950) = 0.001
DPM Mf positivity 6.183 (3.873–9.871) <0.001 2.289 (1.377–3.804) = 0.002
Mf load 1.990 (1.767–2.242) <0.001 1.426 (1.229–1.655) <0.001
Nodules 4.793 (3.699–6.209) <0.001 1.699 (1.251–2.308) = 0.001
Hanging groin Mf positivity 5.594 (3.595–8.703) <0.001 2.179 (1.375–3.454) = 0.002
Mf load 1.823 (1.674–1.985) <0.001 1.297 (1.138–1.478) <0.001
Nodules 7.263 (4.532–11.64) <0.001 2.760 (1.647–4.627) <0.001
Nodules Mf positivity 8.234 (6.031–11.24) <0.001 3.800 (2.539–5.689) <0.001
Mf load 2.631 (2.368–2.923) <0.001 1.858 (1.615–2.137) <0.001
Itching alone or any OSD Mf positivity 3.460 (2.607–4.593) <0.001 2.209 (1.715–2.844) <0.001
Mf load 1.974 (1.722–2.263) <0.001 1.564 (1.385–1.766) <0.001
aAge groups = 5–14,15–24,25–34,35–44,45–54,55–64 and 65+ years
bSex index = female
cmf load = 0,0.01–10.00,10.01–50.00,50.01–100.00 and >100mf / mg skin
dNodules = present or absent
https://doi.org/10.1371/journal.pntd.0005489.t003
Table 4. Prevalences of non-onchocercal skin diseases in endemic and nonendemic villages.
Skin condition Endemic villages N = 6790 Nonendemic villages N = 1343 Univariable ORa (95% CI) P value
n % (95% CI) n % (95% CI)
Acne 970 14.3 (9.4–19.2) 381 28.4 (5.0–51.7) 0.421 (0.276–0.642) <0.001
Pyoderma 622 9.2 (7.3–11.0) 44 3.3 (2.8–3.8) 2.977 (2.373–3.736) <0.001
Scabies 298 4.4 (1.4–7.4) 14 1.0 (0.0–4.5) 4.357 (1.950–9.739) = 0.001
Pityriasis versicolor 234 3.4 (2.4–4.5) 78 5.8 (0.0–20.6) 0.579 (0.372–0.900) = 0.017
Miliaria 203 3.0 (0.0–4.6) 7 0.5 (0.0–6.4) 5.882 (1.441–24.015) = 0.015
Dermatophyte infection 96 1.4 (0.8–2.1) 33 2.5 (1.1–3.8) 0.569 (0.358–0.905) = 0.019
Insect bites 29 0.4 (0.3–0.6) 16 1.2 (0.0–2.9) 0.356 (0.233–0.543) <0.001
Other skin diseases 2,350 34.6 (24.5–44.7) 669 49.8 (14.2–85.4) 0.533 (0.332–0.857) = 0.011
Any non-OSD 3,644 53.7 (40.4–67.0) 928 69.1 (33.0–100) 0.518 (0.294–0.913) = 0.024
aAccount was taken for clustering by village in all analyses. Multivariable OR, corrected for age group and sex revealed similar results (S3 Table).
https://doi.org/10.1371/journal.pntd.0005489.t004
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possible that this may have produced an element of observer bias, but the observers were
masked to all skin snip and eye examination results. The higher prevalence of pyoderma in
endemic communities might be a result of pruritus due to either onchocerciasis or the
higher prevalence of scabies causing excessive excoriation and secondary bacterial infection.
The increased prevalence of other skin diseases in the nonendemic communities might be
explained by small changes such as a wart or keloid being easier to see if the skin was other-
wise clear.
At all ages, microfilarial positivity was an earlier and more sensitive marker of onchocercal
infection than prevalence of nodules (Fig 5). Rapid epidemiological mapping of onchocerciasis
(REMO) followed by rapid epidemiological assessment (REA), the examination of samples of
30–50 adult men for the presence of nodules [20,21], is now a well established and useful
method to quickly assess levels of onchocercal endemicity in areas to decide priorities for mass
drug treatment. Nodule palpation in adult males underestimates the prevalence of infection
compared with the more time-consuming and costly process of skin snipping and quantitative
models have been developed to describe the association and estimate microfilarial ‘prevalence
from measured nodule prevalence [22]. The results presented here suggest a possible further
underestimate as adult females consistently carry the larger burden of disease due to nodules.
The practical difficulties, however, of undressing women in privacy for palpation of nodules
probably outweigh any benefits that might be gained from changing practice.
Since this study was conducted, the skin classification scheme been successfully used in
rain-forest onchocerciasis-endemic areas in Africa [23] as well as in a variety of mass drug
treatment [24;25], psychosocial and economic [26–28], genetic [29] and immunological stud-
ies [30;31].
The multi-country rainforest study [23], which used prevalence of nodules as a marker of
endemicity, confirmed that onchocercal skin disease was a significant public health problem in
affected areas with an overall prevalence of onchocercal skin lesions (excluding nodules) in
those aged 5 years and above of 28%. The prevalence of APOD, CPOD, LOD and depigmenta-
tion was higher in the rainforest areas compared to the findings reported here from a savanna
region. Excluding nodules, the most common form of OSD in rainforest areas was CPOD at
13%, whereas atrophy was the most common in this savanna area. Interestingly atrophy was
the only type of OSD which was more common in the savanna than rain-forest regions.
This savanna study and the later multicountry rainforest skin survey prompted a reassess-
ment of the skin disease burden of onchocerciasis. The rainforest study’s results raised the pos-
sibility that many other endemic rainforest areas across Africa had significant levels of
onchocercal skin disease, and hence merited mass drug treatment, even though they had low
levels of blinding onchocercal eye disease. In 1995, a new control programme, the African Pro-
gramme for Onchocerciasis Control (APOC), was launched. APOC used a sustainable strategy
of community-directed treatment with ivermectin (CDTI) whereby the communities them-
selves implemented annual ivermectin distribution. APOC covered 20 countries and closed in
2015.
A multicountry skin survey after five or six years of annual ivermectin therapy in meso-and
hyperendemic communities [25] revealed significant reductions in the odds ratios of itching
(with and without accompanying OSD), APOD, CPOD, LOD, reactive skin lesions, depigmen-
tation and nodules. Atrophy was not assessed.
The aim of the skin classification system is to facilitate standardisation of data collected by
different observers in different geographical settings and enable comparisons of results.
Observers in the multi-country rainforest study [23] were all trained by the same author (MM)
and underwent an inter-observer variation study prior to data collection. Furthermore several
of the same clinicians collected the data in the multi-country study performed after five or six
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years of ivermectin therapy [25], again following an inter-observer variation study. It is reason-
able to claim therefore that the results from the current study and from these latter two studies
are comparable.
In contrast to the Onchocerciasis Elimination Programme in the Americas (OEPA), which
aimed to eliminate onchocerciasis from foci in Central and Southern America [32], APOC’s
original objective was to try to control onchocerciasis as a public health problem. It was
unclear whether ivermectin could interrupt transmission and eventually eradicate onchocerci-
asis in Africa where the vectors were known to be more efficient. Studies in Mali and Senegal
[33], however, have shown that after 15–17 years of annual or six monthly ivermectin therapy
the prevalence of microfilariae and vector infectivity rates were either zero or below postulated
thresholds for elimination, which triggered revision of APOC’s stated objective to one of elimi-
nation of onchocerciasis in Africa. It is exciting to note that follow up studies in the same
savanna communities reported here reveal that after 15–17 years of annual ivermectin therapy
the community prevalence of mf positivity has fallen to 0%. All 3,703 individuals examined
were skin snip negative [34]. This represents the first evidence from an APOC operational area
that ivermectin treatment alone could eliminate onchocerciasis infection and potentially dis-
ease transmission in endemic areas in Africa.
The need for repeated treatments of ivermectin over many years has led to concerns of
development of ivermectin resistance [35]. Research continues for a macrofilaricidal drug
[36,37].
The pathogenesis of the cutaneous changes in onchocerciasis is still not fully understood.
There is a spectrum of immune response to infection, with some infected persons showing a
minimal immune response to parasite antigens, allowing the proliferation of microfilariae in the
absence of clinical symptoms, while others have an intact and symptomatic immune response
[38]. An immunogenetic basis for this clinical spectrum has been suggested [29;39;40] and differ-
ing isotypic antibody responses [30] and cellular immune responses [31;41–45] may play a role.
The endosymbiotic bacteria Wolbachia are essential for the pathogenesis of O. volvulus keratitis
in a mouse model [46]. The relative Wolbachia DNA burden was previously thought to explain
the difference in ocular pathogenicity of the two strains of O. volvulus [47] but recent whole-
genome data challenges this concept [48]. It is hoped that improved understanding of the patho-
genesis of onchocercal skin disease, including clinico-pathological correlations of how it is
related to human host age, sex and microfilarial load as delineated here, may help in the endeav-
our to identify novel treatments.
The Global Burden of Disease Study has estimated 15,531,500 prevalent cases of onchocer-
ciasis remaining in 2015, representing a 29.1% reduction in global prevalence since 2005.
Based on the skin clinical classification, the disease burden from onchocercal skin disease has
been now included alongside onchocercal eye disease to form an overall global estimate of
1,135,700 years lived with disability (YLDs) due to onchocercal infection [49].
In summary the skin classification scheme for the cutaneous changes in onchocerciasis was
easy to use in the field, reproducible and a useful tool to assess the prevalence of onchocerciasis
skin disease in this savanna region of northern Nigera. We report that the most common onch-
ocercal skin finding was nodules, followed by atrophy, APOD, depigmentation and CPOD.
APOD was more common in males whereas atrophy, hanging groin and nodules were more
common in females. Microfilarial positivity and the presence of nodules were associated with
CPOD, depigmentation and hanging groin. Nodules were also a risk factor for atrophy whereas
microfilarial load showed similar, though weaker associations.
The use of the skin classification scheme in other prevalence and socio-economic studies
has contributed towards an ever-growing body of research which aims to estimate the true
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global disease burden of onchocerciasis, which takes into account not only ophthalmological,
but also cutaneous effects of the disease on its unfortunate sufferers.
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